logo

TELA

TELA Bio·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

TELA fundamentals

TELA Bio (TELA) released its earnings on Nov 13, 2025: revenue was 20.70M (YoY +9.19%), missed estimates; EPS was -0.19 (YoY +54.76%), beat estimates.
Revenue / YoY
20.70M
+9.19%
EPS / YoY
-0.19
+54.76%
Report date
Nov 13, 2025
TELA Earnings Call Summary for Q3,2025
  • Revenue Growth: Q3 2025 revenue up 9% YoY to $20.7 million, driven by U.S. and European expansion.
  • Sales Efficiency: Sales expenses as % of revenue improved to 73.6% (from 89.7% Q1).
  • Strategic Financing: $26 million net cash added via debt refinancing and equity raise.
  • Operational Milestones: 100,000+ implantations, 50+ clinical studies, and NHS U.K. value-based procurement sign-off.
  • 2026 Outlook: Guided for +15% YoY revenue growth, targeting high $20 million breakeven.
EPS
Revenue

Revenue & Expenses

TELA has released its 2025 Q3 earnings report, with revenue of 20.69M, reflecting a YoY change of 9.14%, and net profit of -8.60M, showing a YoY change of 17.06%. The Sankey diagram below clearly presents TELA's revenue sources and cost distribution.

Key Indicators

TELA Bio (TELA) key financial stats and ratios, covering profitability, financial health, and leverage.
TELA Bio (TELA)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
TELA Bio (TELA)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
TELA Bio (TELA)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does TELA Bio (TELA) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track TELA Bio (TELA) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield